| CAS | 317335-37-8 |
| Sequence | H-Cys-Val-Val-Ile-Val-Gly-Arg-Ile-Val-Leu-Ser-Gly-OH |
| Sequence Single | CVVIVGRIVLSG |
| Molecular Formula | C54H99N15O14S |
| Molecular Weight | 1214.54 |
| Technology | Synthetic |
| Storage | -20°C, avoid light, cool and dry place |
| Application | Virology |
| Description | HCV NS4A Protein (22-33) (FDA strain) is a NS4A peptide with the sequence of CVVIVGRIVLSG, it was found to be the minimum domain needed to enhance NS3 proteinase mediated proteolysis. Thus, it might be important for the cofactor activity through complex formation with the NS3 proteinase. This interaction could provide an attractive alternative target for the development of specific proteinase inhibitors as clinically viable antiviral agents. |
HCV NS4A Protein (22-33) (FDA strain)
CAS No.: 317335-37-8
HCV NS4A Protein (22-33) (FDA strain) is a NS4A peptide with the sequence of CVVIVGRIVLSG, it was found to be the minimu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.